Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC
Sacituzumab govitecan (SG) plus pembrolizumab did not demonstrate a statistically significant improvement in progression-free survival compared with pembrolizumab alone as first-line treatment…
September 15, 2026
Ultra-processed foods enter babies’ diets early. What comes with them?
As infants move beyond milk and encounter a wider range of foods, researchers examined how the degree of food processing relates to nutrient intake, dietary diversity and early growth. Study:…
September 15, 2026
September 15, 2026
September 15, 2026
September 14, 2026
September 14, 2026
September 14, 2026
September 14, 2026
September 14, 2026
September 14, 2026
